Copyright
©The Author(s) 2024.
World J Diabetes. Dec 15, 2024; 15(12): 2285-2292
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2285
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2285
Table 1 General characteristics between type 2 diabetes mellitus patients and controls
T2DM (n = 196) | Control (n = 60) | t | P value | |
Age (years) | 72.06 ± 4.87 | 71.82 ± 4.28 | 0.349 | 0.723 |
Course of diabetes mellitus (years) | 15.24 ± 2.08 | - | ||
BMI (kg/m2) | 24.58 ± 2.47 | 25.04 ± 2.45 | 1.261 | 0.208 |
FBG (mmol/L) | 9.69 ± 2.30 | 5.34 ± 0.60 | 14.49 | < 0.0001 |
HbA1c (%) | 9.14 ± 1.78 | 5.64 ± 0.85 | 14.74 | < 0.0001 |
Total cholesterol (mmol/L) | 4.27 ± 1.39 | 4.64 ± 1.03 | 1.897 | 0.059 |
Triglyceride (mmol/L) | 1.73 ± 0.81 | 1.84 ± 0.61 | 0.967 | 0.335 |
High-density lipoprotein (mmol/L) | 1.13 ± 0.30 | 1.26 ± 0.26 | 2.907 | 0.004 |
Low-density lipoprotein (mmol/L) | 2.51 ± 0.92 | 2.86 ± 0.67 | 2.662 | 0.008 |
25(OH)D3 (ng/mL) | 21.87 ± 7.85 | 31.42 ± 9.33 | 7.875 | < 0.0001 |
Femoral neck BMD | 0.76 ± 0.13 | 0.79 ± 0.12 | 1.469 | 0.143 |
Total hip BMD | 0.87 ± 0.14 | 0.95 ± 0.11 | 3.855 | 0.0001 |
Lumbar spine L1-4 BMD | 0.91 ± 0.20 | 0.97 ± 0.16 | 1.612 | 0.108 |
Table 2 Comparison between type 2 diabetes mellitus patients with and without sarcopenia
Sarcopenia group (n = 51) | Non-sarcopenia group (n = 145) | t | P value | |
Age (years) | 71.41 ± 4.87 | 72.29 ± 4.87 | 1.108 | 0.269 |
Course of diabetes mellitus (years) | 16.84 ± 3.31 | 14.68 ± 0.91 | 7.130 | < 0.0001 |
BMI (kg/m2) | 23.11 ± 2.1 | 25.10 ± 2.36 | 5.263 | < 0.0001 |
FBG (mmol/L) | 9.59 ± 2.31 | 9.72 ± 2.30 | 0.369 | 0.712 |
HbA1c (%) | 9.14 ± 1.71 | 9.15 ± 1.81 | 0.010 | 0.992 |
Total cholesterol (mmol/L) | 3.99 ± 1.24 | 4.37 ± 1.43 | 1.668 | 0.097 |
Triglyceride (mmol/L) | 1.54 ± 0.73 | 1.80 ± 0.83 | 1.239 | 0.217 |
High-density lipoprotein (mmol/L) | 1.09 ± 0.25 | 1.15 ± 0.32 | 1.153 | 0.250 |
Low-density lipoprotein (mmol/L) | 2.42 ± 0.86 | 2.55 ± 0.94 | 0.884 | 0.378 |
25(OH)D3 (ng/mL) | 19.17 ± 6.39 | 22.82 ± 8.11 | 2.917 | 0.004 |
Table 3 Comparison of body composition and functional indexes
Sarcopenia group (n = 51) | Non-sarcopenia group (n = 145) | t | P value | |
BMI (kg/m2) | 23.11 ± 2.1 | 25.10 ± 2.36 | 5.263 | < 0.0001 |
ASM (kg) | 19.10 ± 1.60 | 23.42 ± 2.73 | 10.66 | < 0.0001 |
ASMI (kg/m2) | 6.50 ± 0.48 | 8.28 ± 0.52 | 21.44 | < 0.0001 |
Left-hand grip strength (kg) | 25.45 ± 4.03 | 37.68 ± 4.82 | 16.23 | < 0.0001 |
Right-hand grip strength (kg) | 26.45 ± 2.72 | 39.02 ± 4.76 | 17.86 | < 0.0001 |
Gait speed (m/s) | 0.60 ± 0.16 | 1.27 ± 0.16 | 25.91 | < 0.0001 |
Upper limb muscle mass (kg) | 4.82 ± 0.45 | 5.93 ± 0.75 | 10.02 | < 0.0001 |
Lower limb muscle mass (kg) | 15.13 ± 1.28 | 17.74 ± 1.57 | 10.68 | < 0.0001 |
Upper limb fat mass (kg) | 2.58 ± 0.49 | 3.00 ± 0.47 | 5.398 | < 0.0001 |
Lower limb fat mass (kg) | 4.57 ± 1.25 | 5.59 ± 1.49 | 4.398 | < 0.0001 |
Table 4 Correlation between bone mineral density and function in different body parts of diabetic patients
Femoral neck | Total hip | Lumbar spine L1-4 | ||||
r | P value | r | P value | r | P value | |
ASM (kg) | 0.348 | < 0.0001 | 0.309 | < 0.0001 | 0.422 | < 0.0001 |
ASMI (kg/m2) | 0.557 | < 0.0001 | 0.407 | < 0.0001 | 0.582 | < 0.0001 |
Left-hand grip strength (kg) | 0.487 | < 0.0001 | 0.398 | < 0.0001 | 0.557 | < 0.0001 |
Right-hand grip strength (kg) | 0.453 | < 0.0001 | 0.455 | < 0.0001 | 0.598 | < 0.0001 |
Gait speed (m/s) | 0.538 | < 0.0001 | 0.455 | < 0.0001 | 0.612 | < 0.0001 |
Upper limb muscle mass (kg) | 0.438 | < 0.0001 | 0.246 | 0.0005 | 0.368 | < 0.0001 |
Lower limb muscle mass (kg) | 0.447 | < 0.0001 | 0.356 | < 0.0001 | 0.449 | < 0.0001 |
Upper limb fat mass (kg) | 0.264 | 0.0002 | 0.155 | 0.030 | 0.233 | 0.001 |
Lower limb fat mass (kg) | 0.196 | 0.006 | 0.114 | 0.111 | 0.296 | < 0.0001 |
Table 5 Logistic regression analysis of sarcopenia in diabetic patients
Factors | β | SE | Wald | P value | HR | 95%CI |
DM course (> 14.8) | 1.719 | 0.594 | 8.386 | 0.004 | 5.580 | 1.743-17.866 |
BMI (≤ 24.8) | 1.275 | 0.602 | 4.480 | 0.034 | 3.577 | 1.099-11.644 |
25(OH)D3 (≤ 21.58) | 0.362 | 0.580 | 0.389 | 0.533 | 1.436 | 0.461-4.475 |
Femoral neck BMD (≤ 0.76) | 2.610 | 0.703 | 13.776 | 0.000 | 13.594 | 3.427-53.929 |
Total hip BMD (≤ 0.86) | 2.457 | 0.662 | 13.785 | 0.000 | 11.668 | 3.190-42.682 |
Lumbar spine L1-4 BMD (≤ 0.92) | 4.049 | 0.876 | 21.383 | 0.000 | 57.331 | 10.306-318.929 |
Constant | -9.480 | 1.470 | 40.613 | 0.000 | 0.000 | - |
- Citation: Chen DQ, Wu YX, Zhang YX, Yang HL, Huang HH, Lv JY, Xiao Q. Sarcopenia-associated factors and their bone mineral density levels in middle-aged and elderly male type 2 diabetes patients. World J Diabetes 2024; 15(12): 2285-2292
- URL: https://www.wjgnet.com/1948-9358/full/v15/i12/2285.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i12.2285